| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |